6 recruiting. 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Recruiting 6 |
Follow Sleep: new trials by email Literature Review of Sleep trials Research Report on Sleep
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Sleep Health in U.S. Marines Sleep Leadership, Circadian, Light, and Sleep Skills in Shipboard Military (CLASS-MC) Personnel Program, Insomnia Coach - Depression, Suicidality | Phase 2 | Recruiting | San Diego State University | 860 | 2026-03-31 | 2026-04-16 |
| NADream: Effects of Nicotinamide Adenine Dinucleotide Supplementation on Sleep Quality in Healthy Individuals Nicotinamide Riboside (NR), Placebo - Sleep | Phase 2 | Recruiting | Haukeland University Hospital | 16 | 2025-10-13 | 2025-09-15 |
| Cannabis for Palliative Care in Cancer fsCBD Cannabidiol, Placebo, bsCBD Cannabidiol - Sleep, Anxiety | Phase 2 | Recruiting | University of Colorado, Boulder | 185 | 2024-09-16 | 2025-08-01 |
| Cannabidiol and Older Adult Cannabis Users fsCBD Cannabidiol, bsCBD Cannabidiol, Placebo - Sleep, Anxiety | Phase 2 | Recruiting | University of Colorado, Boulder | 385 | 2024-05-01 | 2026-06-10 |
| Sleep Trial to Prevent Alzheimer's Disease Suvorexant 20 mg, Placebo - Sleep, Alzheimer Disease | Phase 2 | Recruiting | University of Minnesota | 120 | 2022-05-25 | 2026-07-13 |
| Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype Cannabidiol (CBD), Tetrahydrocannabinol (THC), Placebo CBD - Multiple Sclerosis, Sleep | Phase 2 | Recruiting | Tiffany J. Braley, MD, MS | 166 | 2022-03-25 | 2026-07-17 |
Depression (3) · Pain (3) · Anxiety Disorders (2) · Alzheimer Disease (1) · Multiple Sclerosis (1) · Plaque, Amyloid (1) · Psychological Well-Being (1) · Sleep Initiation and Maintenance Disorders (1) · Suicidal Ideation (1)
Pathological Conditions, Signs and Symptoms (4) · Behavior (3) · Behavioral Symptoms (3) · Mental Disorders (3) · Neurologic Manifestations (3) · Signs and Symptoms (3) · Nervous System Diseases (2) · Autoimmune Diseases (1) · Autoimmune Diseases of the Nervous System (1) · Brain Diseases (1) · Central Nervous System Diseases (1) · Dementia (1) · Demyelinating Autoimmune Diseases, CNS (1) · Demyelinating Diseases (1) · Dyssomnias (1)
Cannabidiol (1) · Dronabinol (1) · Light (1) · NAD (1) · Solutions (1) · Sugars (1) · nicotinamide-beta-riboside (1) · suvorexant (1)
University of Colorado, Boulder (2) · Haukeland University Hospital (1) · San Diego State University (1) · Tiffany J. Braley, MD, MS (1) · University of Minnesota (1)
United States (5) · Norway (1)
Brendan Lucey, MD (1) · Charalampos Tzoulis, PhD (1) · Emily Schmied, PhD (1) · Katarina Lundervold, MD (1) · Tiffany Braley (1)
2025 (1), R01AT011341 (1)